Tacrolimus and Cranberry drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tacrolimus (tacrolimus) and Cranberry (cranberry). Common drug interactions include food poisoning among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Tacrolimus and Cranberry. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Cranberry?

Cranberry has active ingredients of cranberry. It is often used in urinary tract infection. eHealthMe is studying from 5,399 Cranberry users. Check the latest studies of Cranberry.



On Apr, 23, 2026

67 people who take Tacrolimus and Cranberry together, and have interactions are studied.

Tacrolimus and Cranberry drug interactions.

What are the common drug interactions of Tacrolimus and Cranberry, by gender? *:

female:

  1. Food poisoning (poison in food)
  2. Fungal skin infection
  3. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  4. Herpes zoster
  5. Hidradenitis (chronic disease of a type of sweat gland)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Infective glossitis (tongue can become inflamed or infected)
  8. Inflammation
  9. Influenza
  10. Lung transplant rejection (failure of lung transplant)

male:

  1. Constipation
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Pulmonary congestion (congestion in the lungs)
  4. Wheezing (a high-pitched whistling sound made while you breath)
  5. Lower respiratory tract infection
  6. Asthenia (weakness)
  7. Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
  8. Lumbar vertebral fracture
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Paralysis

What are the common drug interactions of Tacrolimus and Cranberry, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Infection
  2. Decreased appetite
  3. Dehydration (dryness resulting from the removal of water)
  4. Lung transplant rejection (failure of lung transplant)
  5. Tenderness (pain or discomfort when an affected area is touched)
  6. Diarrhoea
  7. Dry skin
  8. Erythema (redness of the skin)
  9. Hypertension (high blood pressure)
  10. Injection site urticaria (rash of round, red welts on the skin at injection site)

30-39:

  1. Decreased appetite
  2. Diarrhoea
  3. Haematochezia (passage of stools containing blood)
  4. Hypotension (abnormally low blood pressure)
  5. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  6. Pneumonia
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

40-49:

n/a

50-59:

  1. Generalised erythema (redness of the skin all over the body)
  2. Ill-defined disorder
  3. Pruritus generalised (generalized itching)
  4. Rash macular (small, flat red spots)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)

60+:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Ulcerative keratitis (ulcerative inflammation of the cornea)
  4. Diarrhoea
  5. Drug ineffective
  6. Fatigue (feeling of tiredness)
  7. Insomnia (sleeplessness)
  8. Constipation
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Neuropathy peripheral (surface nerve damage)

What are the existing conditions these people have? *

  1. Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 25 people, 37.31%
  2. High Blood Pressure: 24 people, 35.82%
  3. Hyperthyroidism (over activity of the thyroid gland): 23 people, 34.33%
  4. Multiple Myeloma (cancer of the plasma cells): 18 people, 26.87%
  5. Prostate Cancer: 16 people, 23.88%
  6. Nausea And Vomiting: 15 people, 22.39%
  7. Nausea (feeling of having an urge to vomit): 15 people, 22.39%
  8. Fluid Retention (an abnormal accumulation of fluid in the blood): 11 people, 16.42%
  9. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 10.45%
  10. Pemphigoid (tense blisters on the skin): 4 people, 5.97%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and Cranberry?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tacrolimus and Cranberry:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cranberry:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tacrolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cranberry and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus and cranberry (the active ingredients of Tacrolimus and Cranberry, respectively), and Tacrolimus and Cranberry (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: